SDGR Logo

Schrödinger, Inc. (SDGR) 

NASDAQ
Market Cap
$1.44B
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
875 of 959
Rank in Industry
40 of 43

Largest Insider Buys in Sector

SDGR Stock Price History Chart

SDGR Stock Performance

About Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. …

Insider Activity of Schrödinger, Inc.

Over the last 12 months, insiders at Schrödinger, Inc. have bought $0 and sold $216,981 worth of Schrödinger, Inc. stock.

On average, over the past 5 years, insiders at Schrödinger, Inc. have bought $14.31M and sold $348.21M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,115 shares for transaction amount of $111,386 was made by Lebowitz Joel (EVP & CFO) on 2021‑02‑05.

List of Insider Buy and Sell Transactions, Schrödinger, Inc.

2024-10-15SaleChief Medical Officer
1,531
0.002%
$17.78$27,226+16.88%
2024-03-04SaleEVP & CFO
3,315
0.0048%
$26.35$87,360-14.30%
2024-02-12SaleEVP, CTO & COO, Software
901
0.0013%
$28.29$25,489-23.54%
2024-02-12SaleEVP, CLO & CPO
758
0.0011%
$28.29$21,444-23.54%
2024-02-12SaleSVP & Controller
787
0.0011%
$28.29$22,264-23.54%
2024-02-12SaleSee Remarks
1,205
0.0016%
$27.55$33,198-23.54%
2023-08-09SaleEVP & Chief Technology Officer
10,000
0.0141%
$40.06$400,642-32.63%
2023-06-30SaleEVP, CLO & CPO
12,040
0.0169%
$50.00$602,000-44.89%
2023-05-23SaleEVP & Chief Technology Officer
10,000
0.0146%
$40.06$400,587-21.63%
2023-05-23SaleEVP, CLO & CPO
7,960
0.0116%
$40.01$318,461-21.63%
2023-05-22SaleEVP, CLO & CPO
15,000
0.0189%
$35.04$525,632-22.16%
2023-05-22Saledirector
14,850
0.0187%
$35.00$519,750-22.16%
2023-02-02SaleEVP & Chief Legal Officer
25,000
0.0345%
$27.26$681,380+8.38%
2023-01-04SalePresident & CEO
66,886
0.0939%
$18.28$1.22M+62.24%
2022-08-11Sale
4,950
0.0078%
$35.00$173,250-16.27%
2021-12-13SaleSee Remarks
15,601
0.0218%
$36.28$565,985-24.80%
2021-10-15SaleSee Remarks
1,393
0.002%
$55.75$77,660-46.13%
2021-09-15SaleSee Remarks
1,394
0.002%
$61.13$85,215-48.42%
2021-09-13SaleSee Remarks
15,602
0.0218%
$61.75$963,435-49.57%
2021-09-02SaleEVP & CFO
3,874
0.0055%
$64.62$250,353-50.90%

Insider Historical Profitability

61.14%
BILL & MELINDA GATES FOUNDATION TRUST10 percent owner
6981664
9.5907%
$19.7313+110.06%
Flynn James E10 percent owner
250000
0.3434%
$19.7310+110.06%
Lebowitz JoelEVP & CFO
0
0%
$19.73113<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$248.22M12.659.19M+4.91%+$11.61M0.01
Bill Melinda Gates Foundation Trust$188.5M9.616.98M0%+$00.41
The Vanguard Group$183.84M9.376.81M+0.48%+$874,611.00<0.01
Baillie Gifford Co$70.52M3.592.61M+0.37%+$259,686.000.06
ARK Investment Management LLC$67.99M3.472.52M-17.54%-$14.46M0.24
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.